$3.25 Billion is the total value of Redmile Group, LLC's 83 reported holdings in Q3 2018. The portfolio turnover from Q2 2018 to Q3 2018 was 46.9% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ARRY | Sell | ARRAY BIOPHARMA INC | $241,782,000 | -9.8% | 15,906,680 | -0.4% | 7.44% | -18.3% |
| ATRA | Buy | ATARA BIOTHERAPEUTICS INC | $174,444,000 | +15.0% | 4,218,717 | +2.2% | 5.37% | +4.2% |
| FATE | Buy | FATE THERAPEUTICS INC | $168,759,000 | +123.6% | 10,359,666 | +55.6% | 5.19% | +102.5% |
| RGNX | Buy | REGENXBIO INC | $125,033,000 | +11.6% | 1,656,065 | +6.1% | 3.85% | +1.1% |
| XNCR | Sell | XENCOR INC | $118,085,000 | +1.4% | 3,030,143 | -3.7% | 3.63% | -8.2% |
| IMGN | Sell | IMMUNOGEN INC | $116,567,000 | -2.7% | 12,309,035 | -0.1% | 3.59% | -11.9% |
| WVE | Buy | WAVE LIFE SCIENCES LTD | $113,665,000 | +32.4% | 2,273,307 | +1.3% | 3.50% | +19.9% |
| ALDR | ALDER BIOPHARMACEUTICALS INC | $108,321,000 | +5.4% | 6,505,766 | 0.0% | 3.33% | -4.6% | |
| FOLD | Sell | AMICUS THERAPEUTICS INC | $101,588,000 | -38.1% | 8,402,617 | -20.1% | 3.12% | -44.0% |
| BOLD | Buy | AUDENTES THERAPEUTICS INC | $88,814,000 | +4.3% | 2,243,356 | +0.7% | 2.73% | -5.6% |
| CI | New | CIGNA CORPORATION | $77,094,000 | – | 370,200 | +100.0% | 2.37% | – |
| LIVN | Sell | LIVANOVA PLC | $74,294,000 | +24.1% | 599,288 | -0.1% | 2.29% | +12.4% |
| ARGX | Buy | ARGENX SEsponsored adr | $73,907,000 | +32.5% | 974,506 | +44.7% | 2.27% | +20.0% |
| IFRX | Sell | INFLARX NV | $69,495,000 | +6.3% | 2,024,900 | -0.1% | 2.14% | -3.7% |
| ALLK | New | ALLAKOS INC | $65,681,000 | – | 1,459,892 | +100.0% | 2.02% | – |
| ANTM | Buy | ANTHEM INC | $64,128,000 | +84.5% | 234,000 | +60.3% | 1.97% | +67.1% |
| WMGI | New | WRIGHT MED GROUP N V | $63,081,000 | – | 2,173,700 | +100.0% | 1.94% | – |
| ANAB | Buy | ANAPTYSBIO INC | $62,880,000 | +70.5% | 630,250 | +21.4% | 1.94% | +54.4% |
| QURE | Buy | UNIQURE NV | $59,676,000 | -2.8% | 1,639,900 | +1.0% | 1.84% | -12.0% |
| DCPH | Sell | DECIPHERA PHARMACEUTICALS IN | $57,173,000 | -1.6% | 1,476,580 | -0.0% | 1.76% | -10.9% |
| CLVS | Buy | CLOVIS ONCOLOGY INC | $52,229,000 | -34.7% | 1,778,300 | +1.1% | 1.61% | -40.8% |
| ICUI | Sell | ICU MED INC | $51,453,000 | -4.9% | 181,972 | -1.2% | 1.58% | -13.8% |
| WCG | Sell | WELLCARE HEALTH PLANS INC | $49,967,000 | -42.8% | 155,909 | -56.1% | 1.54% | -48.2% |
| TNDM | New | TANDEM DIABETES CARE INC | $45,825,000 | – | 1,069,670 | +100.0% | 1.41% | – |
| SRRK | Buy | SCHOLAR ROCK HLDG CORP | $45,658,000 | +67.2% | 1,773,107 | +1.3% | 1.40% | +51.4% |
| NITE | Buy | NIGHTSTAR THERAPEUTICS PLCadr | $42,512,000 | +48.8% | 2,080,846 | +16.5% | 1.31% | +34.8% |
| XERS | Sell | XERIS PHARMACEUTICALS INC | $42,414,000 | -7.4% | 2,412,640 | -0.0% | 1.30% | -16.1% |
| EHTH | Buy | EHEALTH INC | $41,616,000 | +36.7% | 1,472,595 | +6.9% | 1.28% | +23.8% |
| HSKA | Buy | HESKA CORP | $40,982,000 | +11.3% | 361,676 | +1.9% | 1.26% | +0.8% |
| UNH | Buy | UNITEDHEALTH GROUP INC | $38,794,000 | +10.6% | 145,820 | +2.0% | 1.19% | +0.2% |
| BLUE | Sell | BLUEBIRD BIO INC | $36,807,000 | -12.7% | 252,100 | -6.1% | 1.13% | -20.9% |
| OXFD | Buy | OXFORD IMMUNOTEC GLOBAL PLC | $36,281,000 | +25.9% | 2,235,407 | +0.0% | 1.12% | +14.0% |
| REPL | New | REPLIMUNE GROUP INC | $35,307,000 | – | 2,192,957 | +100.0% | 1.09% | – |
| CBAY | Buy | CYMABAY THERAPEUTICS INC | $33,169,000 | -16.4% | 2,993,565 | +1.2% | 1.02% | -24.3% |
| PEN | Buy | PENUMBRA INC | $32,504,000 | +226.0% | 217,129 | +200.9% | 1.00% | +195.0% |
| CNC | Sell | CENTENE CORP DEL | $32,104,000 | -48.7% | 221,745 | -56.3% | 0.99% | -53.5% |
| GRTS | New | GRITSTONE ONCOLOGY INC | $31,935,000 | – | 2,242,636 | +100.0% | 0.98% | – |
| NUVA | New | NUVASIVE INC | $31,210,000 | – | 439,700 | +100.0% | 0.96% | – |
| CVS | New | CVS HEALTH CORP | $31,039,000 | – | 394,300 | +100.0% | 0.96% | – |
| CTLT | Buy | CATALENT INC | $30,466,000 | +9.9% | 668,850 | +1.1% | 0.94% | -0.5% |
| GLYC | Buy | GLYCOMIMETICS INC | $29,493,000 | -9.9% | 2,048,147 | +0.9% | 0.91% | -18.4% |
| TDOC | Buy | TELADOC HEALTH INC | $28,901,000 | +115.5% | 334,700 | +44.9% | 0.89% | +95.0% |
| PRQR | New | PROQR THRAPEUTICS N V | $28,075,000 | – | 1,450,925 | +100.0% | 0.86% | – |
| ALDER BIOPHARMACEUTICALS INCnote 2.500% 2/0 | $26,985,000 | +3.5% | 25,000,000 | 0.0% | 0.83% | -6.3% | ||
| MOR | Sell | MORPHOSYS AGsponsored ads | $24,027,000 | -37.6% | 899,900 | -29.1% | 0.74% | -43.5% |
| EPZM | Buy | EPIZYME INC | $23,831,000 | -13.0% | 2,248,189 | +11.2% | 0.73% | -21.2% |
| ARRAY BIOPHARMA INCnote 2.625%12/0 | $23,717,000 | -7.1% | 19,000,000 | 0.0% | 0.73% | -15.8% | ||
| ZTS | Buy | ZOETIS INCcl a | $23,192,000 | +9.3% | 253,300 | +1.7% | 0.71% | -1.0% |
| LHCG | New | LHC GROUP INC | $22,398,000 | – | 217,480 | +100.0% | 0.69% | – |
| SYNH | Sell | SYNEOS HEALTH INCcl a | $22,088,000 | -52.0% | 428,473 | -56.4% | 0.68% | -56.5% |
| PRAH | New | PRA HEALTH SCIENCES INC | $22,038,000 | – | 200,000 | +100.0% | 0.68% | – |
| A | New | AGILENT TECHNOLOGIES INC | $21,613,000 | – | 306,400 | +100.0% | 0.66% | – |
| SYRS | Buy | SYROS PHARMACEUTICALS INC | $19,725,000 | +18.4% | 1,656,138 | +1.5% | 0.61% | +7.2% |
| ELAN | New | ELANCO ANIMAL HEALTH INC | $18,317,000 | – | 525,000 | +100.0% | 0.56% | – |
| TCDA | Sell | TRICIDA INC | $15,122,000 | +1.2% | 495,000 | -1.0% | 0.46% | -8.5% |
| CMRX | Buy | CHIMERIX INC | $13,969,000 | -18.2% | 3,591,050 | +0.0% | 0.43% | -25.9% |
| ODT | Sell | ODONATE THERAPEUTICS INC | $11,749,000 | -12.9% | 605,300 | -0.9% | 0.36% | -21.2% |
| SGRY | Buy | SURGERY PARTNERS INC | $10,468,000 | +13.1% | 634,400 | +2.1% | 0.32% | +2.5% |
| NVTA | Sell | INVITAE CORP | $8,790,000 | +47.2% | 525,375 | -35.3% | 0.27% | +33.0% |
| EIDX | Buy | EIDOS THERAPEUTICS INC | $8,660,000 | +122.9% | 867,700 | +354.3% | 0.27% | +101.5% |
| IIN | New | INTRICON CORP | $7,025,000 | – | 125,000 | +100.0% | 0.22% | – |
| BGNE | BEIGENE LTDsponsored adr | $6,940,000 | +12.0% | 40,300 | 0.0% | 0.21% | +1.9% | |
| STIM | Sell | NEURONETICS INC | $5,803,000 | -27.3% | 180,999 | -39.7% | 0.18% | -33.9% |
| OVID | Buy | OVID THERAPEUTICS INC | $4,140,000 | +335.3% | 730,150 | +498.7% | 0.13% | +296.9% |
| ESTA | New | ESTABLISHMENT LABS HLDGS INC | $3,615,000 | – | 150,000 | +100.0% | 0.11% | – |
| JNCE | Sell | JOUNCE THERAPEUTICS INC | $2,765,000 | -70.3% | 425,415 | -65.0% | 0.08% | -73.1% |
| ARVN | New | ARVINAS INC | $2,299,000 | – | 136,300 | +100.0% | 0.07% | – |
| ELGX | Sell | ENDOLOGIX INC | $1,548,000 | -93.7% | 810,461 | -81.3% | 0.05% | -94.2% |
| RMED | New | RA MED SYS INC | $1,547,000 | – | 85,000 | +100.0% | 0.05% | – |
| RGEN | New | REPLIGEN CORP | $1,109,000 | – | 20,000 | +100.0% | 0.03% | – |
| VKTX | New | VIKING THERAPEUTICS INC | $523,000 | – | 30,000 | +100.0% | 0.02% | – |
| MYOK | MYOKARDIA INC | $467,000 | +31.2% | 7,170 | 0.0% | 0.01% | +16.7% | |
| IHF | ISHARES TRus hlthcr pr etf | $417,000 | +13.6% | 2,087 | 0.0% | 0.01% | +8.3% | |
| HRTX | New | HERON THERAPEUTICS INC | $343,000 | – | 10,850 | +100.0% | 0.01% | – |
| AMED | AMEDISYS INC | $341,000 | +46.4% | 2,725 | 0.0% | 0.01% | +25.0% | |
| SAGE | SAGE THERAPEUTICS INC | $307,000 | -9.7% | 2,170 | 0.0% | 0.01% | -25.0% | |
| VCEL | Sell | VERICEL CORP | $283,000 | -83.9% | 20,000 | -88.9% | 0.01% | -85.0% |
| FLXN | FLEXION THERAPEUTICS INC | $248,000 | -27.7% | 13,260 | 0.0% | 0.01% | -33.3% | |
| JAZZ | JAZZ PHARMACEUTICALS PLC | $267,000 | -2.6% | 1,590 | 0.0% | 0.01% | -11.1% | |
| SENS | Sell | SENSEONICS HLDGS INC | $214,000 | -96.0% | 44,900 | -96.6% | 0.01% | -96.2% |
| ACRS | Sell | ACLARIS THERAPEUTICS INC | $164,000 | -92.3% | 11,320 | -89.4% | 0.01% | -93.1% |
| ADVM | ADVERUM BIOTECHNOLOGIES INC | $135,000 | +14.4% | 22,236 | 0.0% | 0.00% | 0.0% | |
| CSLT | CASTLIGHT HEALTH INCcl b | $28,000 | -34.9% | 10,229 | 0.0% | 0.00% | 0.0% | |
| ARAY | Exit | ACCURAY INC | $0 | – | -29,000 | -100.0% | -0.00% | – |
| VRAY | Exit | VIEWRAY INC | $0 | – | -24,330 | -100.0% | -0.01% | – |
| VRX | Exit | VALEANT PHARMACEUTICALS INTL | $0 | – | -8,930 | -100.0% | -0.01% | – |
| NVRO | Exit | NEVRO CORP | $0 | – | -3,400 | -100.0% | -0.01% | – |
| HZNP | Exit | HORIZON PHARMA PLC | $0 | – | -25,800 | -100.0% | -0.02% | – |
| LIFE | Exit | ATYR PHARMA INC | $0 | – | -1,884,992 | -100.0% | -0.06% | – |
| UBX | Exit | UNITY BIOTECHNOLOGY INC | $0 | – | -250,400 | -100.0% | -0.13% | – |
| SRPT | Exit | SAREPTA THERAPEUTICS INC | $0 | – | -31,100 | -100.0% | -0.14% | – |
| CTMX | Exit | CYTOMX THERAPEUTICS INC | $0 | – | -262,400 | -100.0% | -0.20% | – |
| INSP | Exit | INSPIRE MED SYS INC | $0 | – | -200,000 | -100.0% | -0.24% | – |
| VTL | Exit | VITAL THERAPIES INC | $0 | – | -1,095,111 | -100.0% | -0.26% | – |
| NLNK | Exit | NEWLINK GENETICS CORP | $0 | – | -1,611,746 | -100.0% | -0.26% | – |
| TFX | Exit | TELEFLEX INC | $0 | – | -79,886 | -100.0% | -0.73% | – |
| ABT | Exit | ABBOTT LABS | $0 | – | -449,300 | -100.0% | -0.93% | – |
| IRTC | Exit | IRHYTHM TECHNOLOGIES INC | $0 | – | -401,303 | -100.0% | -1.11% | – |
| INSM | Exit | INSMED INC | $0 | – | -2,033,492 | -100.0% | -1.63% | – |
| LH | Exit | LABORATORY CORP AMER HLDGS | $0 | – | -288,400 | -100.0% | -1.76% | – |
| ALXN | Exit | ALEXION PHARMACEUTICALS INC | $0 | – | -489,300 | -100.0% | -2.06% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR/A filed 2019-05-16
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| AMICUS THERAPEUTICS INC | 43 | Q3 2023 | 10.1% |
| ATARA BIOTHERAPEUTICS INC | 36 | Q3 2023 | 6.4% |
| FATE THERAPEUTICS INC | 34 | Q3 2023 | 17.2% |
| INVITAE CORP | 32 | Q3 2023 | 2.7% |
| REGENXBIO INC | 28 | Q3 2023 | 3.8% |
| CLOVIS ONCOLOGY INC | 27 | Q1 2020 | 6.7% |
| IMMUNOGEN INC | 27 | Q3 2023 | 13.2% |
| CASTLIGHT HEALTH INC SAN FRAN COM STK | 27 | Q1 2021 | 2.5% |
| ARRAY BIOPHARMA INC | 26 | Q2 2019 | 12.6% |
| DECIPHERA PHARMACEUTICALS IN | 25 | Q3 2023 | 7.0% |
View Redmile Group, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Neoleukin Therapeutics, Inc. | July 27, 2023 | 2,912,228 | 6.6% |
| IGM Biosciences, Inc. | June 28, 2023 | 3,291,092 | 9.9% |
| MedAvail Holdings, Inc. | June 21, 2023 | 124,507,268 | 73.1% |
| Achilles Therapeutics plc | February 14, 2023 | 1,608,089 | 3.9% |
| Kymera Therapeutics, Inc. | February 14, 2023 | 2,673,837 | 4.9% |
| Old Ayala, IncSold out | February 08, 2023 | 0 | 0.0% |
| Zymeworks Inc. | August 08, 2022 | 5,758,241 | 9.9% |
| Science 37 Holdings, Inc. | June 15, 2022 | 19,808,234 | 17.1% |
| Allakos Inc. | February 14, 2022 | 2,077,875 | 3.8% |
| Aprea Therapeutics, Inc.Sold out | February 14, 2022 | 0 | 0.0% |
View Redmile Group, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 4 | 2024-04-01 |
| 4 | 2024-04-01 |
| 4 | 2024-03-25 |
| SC 13D/A | 2024-03-25 |
| 4 | 2024-03-19 |
| 4 | 2024-03-14 |
| 4 | 2024-03-13 |
| SC 13D/A | 2024-03-13 |
| 4 | 2024-03-05 |
| SC 13D/A | 2024-03-05 |
View Redmile Group, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.